This session will equip healthcare professionals with evidence-based insights and actionable strategies to improve COPD care, reduce hospitalizations, and enhance survival rates through optimized treatment and inhaler use.
If you are a healthcare professional working with COPD patients, this webinar is a must-attend event that will change the way you approach treatment. Exacerbations in COPD are not just setbacks—they are life-threatening events that drive mortality. With new evidence confirming that triple therapy goes beyond symptom control to actively reduce mortality, mortality all causes and cardiovascular specific mortality, it is time to rethink our approach to COPD management.
As a physician, you will gain practical, evidence-based strategies to overcome common barriers to triple therapy adoption, ensuring your patients receive the best possible care based on the latest guidelines. If you are an educator, this session will equip you with the knowledge and tools to train others in optimizing COPD treatment, addressing inhaler technique, clinical inertia, and under-prescription in Canada.
The future of COPD treatment is proactive, personalized, and life-saving—this webinar will give you the knowledge and confidence to lead that change.
By the end of this webinar, participants will be able to:
Recognize the Life-Saving Impact of Triple Therapy – Understand how COPD exacerbations significantly contribute to mortality and how triple therapy goes beyond symptom control to prevent exacerbations and reduce mortality.
Address Barriers to Triple Therapy Adoption – Identify key challenges, including clinical inertia, misconceptions, and under prescription in Canada, despite its endorsement in the 2023 COPD Guidelines. Learn practical strategies to confidently initiate triple therapy in appropriate patients.
Optimize Inhaler Use for Better Patient Outcomes – Explore how proper inhaler technique and patient-centered device selection can enhance treatment adherence and effectiveness. Understand the role of training and education in ensuring optimal therapy delivery.
In Check DIAL is an inspiratory flow meter with a turnable dial which when turned, changes the resistance that an individual is inhaling through. The engineering of the device is such that the different resistances mimic the resistances found when inhaling through the diverse medication inhalers
This program has received educational funding from AstraZeneca, supporting RESPIPLUS in delivering valuable insights on pneumococcal vaccination for healthcare professionals.
This webinar is only for healthcare professionals.
Respirologist - MD, MSc, FRCPc
MD, FRCPC
